Editorial: Targeting MYCN in Pediatric Cancers. - Wikidata - thesis-toulmin - TriplyDB

Editorial: Targeting MYCN in Pediatric Cancers.

Editorial: Targeting MYCN in Pediatric Cancers.

http://www.wikidata.org/entity/Q40606235

about

Editorial: Targeting MYCN in Pediatric Cancers.

http://www.wikidata.org/entity/Q40606235

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Editorial: Targeting MYCN in Pediatric Cancers.

@en

type

label

Editorial: Targeting MYCN in Pediatric Cancers.

@en

prefLabel

Editorial: Targeting MYCN in Pediatric Cancers.

@en

P1433

Q40606235-1E2ABBED-0C00-4CBF-9386-F9AF859112A1

P1476

Q40606235-A9A8968F-48AB-4889-A3BB-8F84BCCBB318

P2093

Q40606235-A98E2CAD-1994-4E12-80DD-A1DB541285C9

P2860

Q40606235-010CA23E-AA9E-487C-AC22-3912F3F543EE

Q40606235-1BACDA3E-32F7-411C-9019-EE826AF7FC8E

Q40606235-21CE46F3-3C01-4239-90B9-2CE7DF6CBE05

Q40606235-37CD83EA-B8CA-4A20-A7C3-7572D1CD836E

Q40606235-4636C629-714B-4824-89B0-C1D08D3BE50A

Q40606235-4688FEE0-C050-49D8-940B-104593B56F34

Q40606235-5ECE119E-F600-462C-9436-A6DE8F201030

Q40606235-60B4C48F-D45E-4D3E-ABB6-40C05E6BF6EA

Q40606235-6F25A310-B411-49E6-9CCA-F3F74202A590

Q40606235-A37F8D53-95CF-48A6-A29E-63F51B7A738E

P304

Q40606235-7EF9F33F-76BC-41E2-93C0-5B57DC239C06

P31

Q40606235-4e90369c-d899-422c-aa8a-e64aa1de3900

Q40606235-C0C137D6-D7A4-45A0-9922-295F1EEF506E

P356

Q40606235-F90FA089-80EF-42AD-A27D-A5651974B82B

P478

Q40606235-BEC980FE-4EA0-4A80-86D3-920A35ED8C50

P577

Q40606235-BF86C993-217D-4E98-8D3F-C7B046DA606D

P5875

Q40606235-4CE297D9-A7E8-4BF9-A285-D24C692CCBAF

P698

Q40606235-83EDABC2-C2A9-4A3A-B4B1-B780D391F47D

P932

Q40606235-16CF3FB6-44B9-456A-A3FF-987882A41C49

P356

FONC.2014.00330

P1433

Frontiers in Oncology

P1476

Editorial: Targeting MYCN in Pediatric Cancers.

@en

P2093

Arturo Sala

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma

The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors

Targeted expression of MYCN causes neuroblastoma in transgenic mice.

The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma

Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis.

Molecular mechanisms of MYCN-dependent apoptosis and the MDM2-p53 pathway: an Achille's heel to be exploited for the therapy of MYCN-amplified neuroblastoma.

EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR

MYCN and the epigenome

Targeting MYCN in neuroblastoma by BET bromodomain inhibition

MYCN-mediated transcriptional repression in neuroblastoma: the other side of the coin.

P304

330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2014.00330

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277351877

http://www.w3.org/2001/XMLSchema#string

P698

26029658

http://www.w3.org/2001/XMLSchema#string

P932

4429566

http://www.w3.org/2001/XMLSchema#string